BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MN1, Q10571, MGCR1-PEN, MGCR1, MGCR, dJ353E16_2, ENSG00000169184, 4330 AND Diagnosis
6610 results:

  • 1. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune checkpoint inhibitor associated diarrhoea.
    Al-Hussainy A; Adams J; Simmons J; Kennedy J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719255
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable pancreatic cancer: Protocol for a Prospective Validation Study.
    Seeger N; Gutknecht S; Zschokke I; Fleischmann I; Roth N; Metzger J; Weber M; Breitenstein S; Grochola LF
    JMIR Res Protoc; 2024 May; 13():e54042. PubMed ID: 38635586
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Blood-Based Multiomics-Guided Detection of a Precancerous pancreatic Tumor.
    Anwar MA; Keshteli AH; Yang H; Wang W; Li X; Messier HM; Cullis PR; Borchers CH; Fraser R; Wishart DS
    OMICS; 2024 Apr; 28(4):182-192. PubMed ID: 38634790
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies.
    Olah C; Kubik A; Mátrai P; Engh MA; Barna V; Hegyi P; Reis H; Nyirády P; Szarvas T
    Urol Oncol; 2024 Jul; 42(7):221.e1-221.e7. PubMed ID: 38627107
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Codetection of Proteins and RNAs on Extracellular Vesicles for pancreatic cancer Early diagnosis.
    He J; Long J; Zhai C; Xu J; Bao K; Su W; Jiang L; Shen G; Ding X
    Anal Chem; 2024 Apr; 96(17):6618-6627. PubMed ID: 38626343
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer.
    Zhang LT; Zhang Y; Cao BY; Wu CC; Wang J
    World J Gastroenterol; 2024 Mar; 30(12):1739-1750. PubMed ID: 38617739
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder cancer with Direct Hepatic Invasion.
    Qiu S; Liu Z; Hu J; Wang Z; Yue Z; Jia Z; Zhang W; Xue Z; Liu Z; Liu Y
    Int J Med Sci; 2024; 21(5):862-873. PubMed ID: 38617005
    [No Abstract]    [Full Text] [Related]  

  • 9. Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma.
    Liu Q; Zhu J; Huang Z; Zhang X; Yang J
    Technol Cancer Res Treat; 2024; 23():15330338241239139. PubMed ID: 38613350
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma.
    López JC; Ielpo B; Iglesias M; Pinilla FB; Sánchez-Velázquez P
    Langenbecks Arch Surg; 2024 Apr; 409(1):122. PubMed ID: 38607450
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
    Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
    BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Associations between diabetes and cancer: A 10-year national population-based retrospective cohort study.
    Safadi H; Balogh Á; Lám J; Nagy A; Belicza É
    Diabetes Res Clin Pract; 2024 May; 211():111665. PubMed ID: 38604444
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks.
    Cordeiro HG; Azevedo-Martins JM; Faria AVS; Rocha-Brito KJP; Milani R; Peppelenbosch M; Fuhler G; de Fátima Â; Ferreira-Halder CV
    Cell Signal; 2024 Jul; 119():111174. PubMed ID: 38604340
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy.
    Tang H; Dilimulati D; Yang Z; Zhou K; Chen X; Sun R; Wang N; Liang Z; Bian S; Zhao J; Song P; Zheng S; Wang H; Xie H
    EBioMedicine; 2024 May; 103():105099. PubMed ID: 38604089
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Total pancreatectomy, splenectomy and remnant gastrectomy for invasive intraductal papillary mucinous neoplasm (IPMN) after prior Roux-en-Y gastric bypass.
    Buchheit JT; Joshi I; Dixon ME; Peng JS
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38594195
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report.
    Kong YH; Xu ML; Zhang JJ; Chen GQ; Hong ZH; Zhang H; Dai XX; Ma YF; Zhao XR; Zhang CY; Chen RZ; Xing PF; Zhang LY
    World J Gastroenterol; 2024 Mar; 30(9):1237-1249. PubMed ID: 38577174
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
    Martínez-Moral MP; Tena MT; Martín-Carnicero A; Martínez A
    Clin Chim Acta; 2024 Apr; 557():117895. PubMed ID: 38561063
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Performance of Intracystic Glucose Measurement for the Characterization of pancreatic Cystic Lesions.
    Ribeiro T; Lopes S; Moutinho-Ribeiro P; Macedo G; Vilas-Boas F
    J Gastrointestin Liver Dis; 2024 Mar; 33(1):74-78. PubMed ID: 38554431
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 331.